FDA Asks Novo, Lilly To Remove Suicide Warnings From GLP-1 Weight Loss Products
A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.
FDA Asks Novo, Lilly To Remove Suicide Warnings From GLP-1 Weight Loss Products Read More »
